Trinity Health System electrophysiologist, Maninder Bedi, MD implanted the world’s smallest and thinnest cardioverter defibrillator to treat heart failure and sudden cardiac arrest on Tuesday. This was the first implant of its kind in Ohio and the fifth in the US.
Dr. Maninder Bedi implanted an INCEPTA, a Boston Scientific device, into a patient at Trinity Health System this week. The patient was being treated for ventricular arrhythmias.
“Boston Scientific has given physicians the opportunity to better treat our patients while fulfilling the requests of what patients say they want – smaller, thinner and long-lasting devices that perform when needed,” said Bedi. “In addition, the new device is easier and quicker to implant, enhancing patient comfort.”
The U.S. Food and Drug Administration approved three new Boston Scientific resynchronization therapy defibrillators and implantable cardioverter defibrillators, including INCEPTA in November 2011.
In addition to its exclusive smaller size, the other advantage of INCEPTA is its 10-year warranty; nearly double that of its competitors.
According to Keith Murdock, Trinity Spokesman, “Trinity’s Heart Center continues to lead the way in cardiac care and this procedure exemplifies our commitment to leading edge technologies.”
Dr. Bedi added, “Some patients have Web-based monitors placed in their homes that communicate with the device. Through this technology, physicians can remotely monitor a patient’s vital signs and device function. This helps us better manage their very complex disease. In a survival study, patients with remote monitoring had a lower mortality rate.”